Mood Stabilizer [EPC]

Mood Stabilizer [EPC] was reported 219861 times

Drugs of the Mood Stabilizer [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 247 0.4617
1 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 274 0.4215
2 LIP EROSION 276 0.3781
3 ANTICONVULSANT DRUG LEVEL INCREASED 574 0.3552
4 MULTIPLE-DRUG RESISTANCE 993 0.3199
5 HYPERAMMONAEMIC ENCEPHALOPATHY 537 0.3086
6 FOETAL ANTICONVULSANT SYNDROME 362 0.3052
7 COMPLEX PARTIAL SEIZURES 304 0.2734
8 ANTICONVULSANT DRUG LEVEL DECREASED 377 0.2668
9 SEDATION COMPLICATION 669 0.2619
10 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 194 0.2576
11 ORAL MUCOSA EROSION 315 0.2561
12 MYOCLONIC EPILEPSY 381 0.2510
13 FACET JOINT SYNDROME 799 0.2452
14 PETIT MAL EPILEPSY 1218 0.2383
15 FOCAL DYSCOGNITIVE SEIZURES 269 0.2362
16 ATONIC SEIZURES 199 0.2317
17 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 751 0.2311
18 CHANGE IN SEIZURE PRESENTATION 142 0.2195
19 SEIZURE CLUSTER 179 0.2159
20 DYSMORPHISM 506 0.2146
21 AURA 386 0.2067
22 OVERLAP SYNDROME 143 0.2043
23 PSYCHOGENIC SEIZURE 189 0.2021
24 PARTIAL SEIZURES 991 0.1890
25 STATUS EPILEPTICUS 2094 0.1852
26 EPILEPSY 5624 0.1838
27 SIMPLE PARTIAL SEIZURES 145 0.1797
28 HYPERAMMONAEMIA 877 0.1752
29 HYPOSPADIAS 358 0.1720
30 TONIC CONVULSION 242 0.1707
31 HYPOMANIA 621 0.1687
32 ONYCHOMADESIS 700 0.1666
33 PERIPHERAL VENOUS DISEASE 678 0.1659
34 BLEPHAROSPASM 1044 0.1656
35 STEVENS-JOHNSON SYNDROME 3606 0.1620
36 SELECTIVE EATING DISORDER 147 0.1615
37 MUCOSAL EROSION 146 0.1604
38 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4044 0.1570
39 ELECTROENCEPHALOGRAM ABNORMAL 474 0.1500
40 GENERALISED TONIC-CLONIC SEIZURE 2419 0.1460
41 NYSTAGMUS 774 0.1457
42 SCHIZOAFFECTIVE DISORDER 260 0.1457
43 CREATININE RENAL CLEARANCE DECREASED 577 0.1440
44 INTELLECTUAL DISABILITY 215 0.1415
45 TRIGEMINAL NEURALGIA 566 0.1406
46 ATAXIA 1658 0.1396
47 POLYDACTYLY 160 0.1379
48 BREAST CANCER STAGE III 875 0.1350
49 SPINA BIFIDA 278 0.1333
50 PSYCHOMOTOR RETARDATION 368 0.1308
51 PSYCHOMOTOR SKILLS IMPAIRED 340 0.1297
52 GRAND MAL CONVULSION 1194 0.1292
53 TOXIC EPIDERMAL NECROLYSIS 1933 0.1272
54 CLEFT PALATE 240 0.1241
55 DRUG WITHDRAWAL CONVULSIONS 215 0.1208
56 MICROCEPHALY 154 0.1200
57 RHEUMATIC FEVER 531 0.1190
58 DUODENAL ULCER PERFORATION 872 0.1171
59 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 837 0.1167
60 RESPIRATORY DISORDER NEONATAL 189 0.1165
61 MUCOUS MEMBRANE DISORDER 157 0.1149
62 LIVE BIRTH 960 0.1146
63 ONYCHOMYCOSIS 499 0.1136
64 BIPOLAR I DISORDER 247 0.1125
65 CEREBELLAR SYNDROME 242 0.1104
66 CONVULSION 6264 0.1094
67 HYPOTONIA NEONATAL 160 0.1024
68 DRUG LEVEL INCREASED 1695 0.1023
69 TALIPES 314 0.1010
70 GAZE PALSY 172 0.1009
71 BIPOLAR DISORDER 1088 0.1000
72 PSYCHIATRIC DECOMPENSATION 193 0.0987
73 SEIZURE 11370 0.0983
74 NEUROLEPTIC MALIGNANT SYNDROME 1157 0.0975
75 MANIA 1578 0.0958
76 RASH MORBILLIFORM 264 0.0951
77 OCULOGYRIC CRISIS 204 0.0950
78 ANTIPSYCHOTIC DRUG LEVEL INCREASED 263 0.0933
79 DISLOCATION OF VERTEBRA 210 0.0920
80 SPEECH DISORDER DEVELOPMENTAL 264 0.0920
81 DEPRESSIVE SYMPTOM 322 0.0912
82 WRONG PATIENT RECEIVED PRODUCT 266 0.0908
83 MUSCLE INJURY 751 0.0905
84 NAIL DISORDER 791 0.0903
85 VENTRICULAR SEPTAL DEFECT 510 0.0890
86 HUMAN HERPESVIRUS 6 INFECTION 168 0.0888
87 BEHAVIOUR DISORDER 479 0.0885
88 FOLLICULITIS 907 0.0864
89 ATRIAL SEPTAL DEFECT 723 0.0862
90 HELICOBACTER INFECTION 886 0.0861
91 LIP DRY 775 0.0852
92 DRUG ERUPTION 1503 0.0847
93 CONJUNCTIVAL HYPERAEMIA 302 0.0846
94 HYPERCHOLESTEROLAEMIA 811 0.0839
95 PERSECUTORY DELUSION 209 0.0837
96 SEDATION 2176 0.0830
97 SUSPECTED SUICIDE 386 0.0823
98 INFUSION SITE REACTION 245 0.0819
99 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 411 0.0801
100 MYOCLONUS 947 0.0793
101 MATERNAL DRUGS AFFECTING FOETUS 607 0.0791
102 STARING 191 0.0790
103 PATENT DUCTUS ARTERIOSUS 313 0.0788
104 PEMPHIGUS 980 0.0783
105 CEREBRAL ATROPHY 312 0.0782
106 CATATONIA 410 0.0780
107 BURSITIS 945 0.0778
108 HYPERREFLEXIA 271 0.0777
109 OBESITY 1233 0.0773
110 DRUG LEVEL DECREASED 787 0.0772
111 CLONUS 210 0.0767
112 WOUND INFECTION 837 0.0764
113 CONGENITAL ANOMALY 578 0.0746
114 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 308 0.0741
115 AMMONIA INCREASED 372 0.0728
116 FINGER DEFORMITY 353 0.0728
117 STUPOR 233 0.0725
118 CLUMSINESS 197 0.0721
119 HAND DEFORMITY 932 0.0710
120 PARADOXICAL DRUG REACTION 261 0.0709
121 BRAIN OPERATION 160 0.0700
122 LOGORRHOEA 245 0.0695
123 COORDINATION ABNORMAL 968 0.0693
124 OBSESSIVE-COMPULSIVE DISORDER 545 0.0678
125 C-REACTIVE PROTEIN ABNORMAL 434 0.0676
126 DRUG EXPOSURE DURING PREGNANCY 2300 0.0675
127 RASH MACULO-PAPULAR 1503 0.0675
128 DRUG INTERACTION 10650 0.0671
129 SCHIZOPHRENIA 814 0.0669
130 PERSONALITY DISORDER 175 0.0667
131 DERMATITIS EXFOLIATIVE 333 0.0665
132 BACK INJURY 723 0.0664
133 GENERALISED ERYTHEMA 377 0.0662
134 ERYTHEMA MULTIFORME 618 0.0662
135 HYPERNATRAEMIA 330 0.0662
136 STRABISMUS 192 0.0653
137 COMPLETED SUICIDE 5391 0.0646
138 PERICARDITIS 1086 0.0646
139 GAMBLING DISORDER 172 0.0636
140 COMA SCALE ABNORMAL 184 0.0634
141 GRIP STRENGTH DECREASED 548 0.0622
142 FOETAL EXPOSURE DURING PREGNANCY 5051 0.0621
143 EXPOSURE VIA BREAST MILK 247 0.0620
144 NEONATAL RESPIRATORY DISTRESS SYNDROME 218 0.0615
145 PARKINSONISM 598 0.0613
146 IMPULSIVE BEHAVIOUR 229 0.0610
147 LEARNING DISORDER 147 0.0609
148 DEPRESSED LEVEL OF CONSCIOUSNESS 2380 0.0601
149 JAUNDICE CHOLESTATIC 212 0.0600
150 DRUG SCREEN FALSE POSITIVE 166 0.0599
151 JOINT RANGE OF MOTION DECREASED 804 0.0599
152 INTENTIONAL SELF-INJURY 1206 0.0596
153 BLOOD CALCIUM DECREASED 671 0.0596
154 TACHYPHRENIA 205 0.0591
155 HYPERTHERMIA 451 0.0590
156 AGGRESSION 2953 0.0589
157 HEPATOSPLENOMEGALY 151 0.0588
158 PSYCHOTIC DISORDER 1729 0.0585
159 STILLBIRTH 282 0.0583
160 SUICIDE ATTEMPT 3517 0.0579
161 DIPLOPIA 1503 0.0578
162 HYPOTONIA 574 0.0574
163 TOXIC SKIN ERUPTION 571 0.0566
164 AUTISM SPECTRUM DISORDER 312 0.0566
165 INTENTIONAL OVERDOSE 3587 0.0559
166 DEPRESSION SUICIDAL 193 0.0557
167 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 572 0.0557
168 MATERNAL EXPOSURE DURING BREAST FEEDING 226 0.0557
169 PRODUCT LABEL CONFUSION 324 0.0555
170 AFFECTIVE DISORDER 435 0.0553
171 COGNITIVE DISORDER 2582 0.0552
172 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 411 0.0547
173 ORTHOSTATIC HYPOTENSION 951 0.0546
174 SEROTONIN SYNDROME 1048 0.0545
175 SKIN EROSION 174 0.0540
176 COMA 2562 0.0537
177 ENURESIS 217 0.0537
178 NORMAL NEWBORN 291 0.0535
179 ALTERED STATE OF CONSCIOUSNESS 1159 0.0534
180 DRUG LEVEL BELOW THERAPEUTIC 294 0.0532
181 POISONING DELIBERATE 504 0.0531
182 SUICIDAL BEHAVIOUR 221 0.0531
183 SALIVARY HYPERSECRETION 531 0.0530
184 EOSINOPHILIA 928 0.0529
185 GLOSSODYNIA 1180 0.0527
186 SYNOVITIS 946 0.0524
187 MULTIPLE DRUG OVERDOSE INTENTIONAL 166 0.0516
188 TOXICITY TO VARIOUS AGENTS 8690 0.0515
189 TOXIC ENCEPHALOPATHY 259 0.0511
190 MENINGITIS ASEPTIC 227 0.0505
191 POISONING 635 0.0505
192 NORMOCHROMIC NORMOCYTIC ANAEMIA 151 0.0502
193 PSYCHOMOTOR HYPERACTIVITY 828 0.0498
194 TEARFULNESS 214 0.0497
195 HALLUCINATION, AUDITORY 787 0.0495
196 LYMPHADENOPATHY 1748 0.0493
197 EYE MOVEMENT DISORDER 337 0.0492
198 ABORTION INDUCED 463 0.0491
199 RESPIRATORY ACIDOSIS 193 0.0490
200 DRUG TOXICITY 666 0.0488
201 AKATHISIA 664 0.0486
202 SOPOR 644 0.0486
203 HOMICIDAL IDEATION 197 0.0485
204 HYPERTONIA 277 0.0483
205 COELIAC DISEASE 472 0.0481
206 SWOLLEN JOINT COUNT INCREASED 153 0.0479
207 SELF INJURIOUS BEHAVIOUR 146 0.0478
208 RASH VESICULAR 231 0.0477
209 MUSCLE RIGIDITY 571 0.0477
210 SMALL FOR DATES BABY 237 0.0477
211 POSTURE ABNORMAL 155 0.0476
212 DYSARTHRIA 1787 0.0474
213 TYPE 2 DIABETES MELLITUS 1593 0.0473
214 FIBROMYALGIA 1146 0.0471
215 MAJOR DEPRESSION 343 0.0469
216 HYPOGAMMAGLOBULINAEMIA 307 0.0467
217 C-REACTIVE PROTEIN INCREASED 1700 0.0467
218 IRRITABLE BOWEL SYNDROME 1001 0.0466
219 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1028 0.0463
220 BRADYPHRENIA 302 0.0462
221 EXPOSURE DURING BREAST FEEDING 150 0.0452
222 BRUXISM 242 0.0448
223 POLYDIPSIA 177 0.0447
224 DELUSION 693 0.0446
225 PARANOIA 769 0.0446
226 BLOOD PROLACTIN INCREASED 210 0.0445
227 HALLUCINATIONS, MIXED 187 0.0444
228 HYPERACUSIS 165 0.0443
229 EXPOSURE DURING PREGNANCY 2755 0.0443
230 AGITATION 3240 0.0441
231 DRUG LEVEL ABOVE THERAPEUTIC 202 0.0441
232 TASTE DISORDER 892 0.0439
233 ABNORMAL BEHAVIOUR 1740 0.0439
234 PSYCHIATRIC SYMPTOM 324 0.0439
235 HYPOTHERMIA 444 0.0438
236 LIVER INJURY 1075 0.0438
237 POTENTIATING DRUG INTERACTION 146 0.0435
238 MATERNAL EXPOSURE DURING PREGNANCY 3877 0.0435
239 FEELING DRUNK 323 0.0434
240 ANXIETY DISORDER 145 0.0434
241 ENCEPHALOPATHY 1064 0.0433
242 DEVELOPMENTAL DELAY 390 0.0432
243 ABORTION SPONTANEOUS 1725 0.0430
244 TIC 234 0.0429
245 RASH GENERALISED 1109 0.0428
246 CHEILITIS 231 0.0427
247 HEART DISEASE CONGENITAL 151 0.0426
248 HYPONATRAEMIA 2391 0.0424
249 SUICIDAL IDEATION 3865 0.0422
250 MULTIPLE DRUG OVERDOSE 207 0.0417
251 COMMUNICATION DISORDER 156 0.0408
252 GESTATIONAL DIABETES 194 0.0407
253 FACE OEDEMA 685 0.0406
254 DIABETIC NEUROPATHY 201 0.0406
255 WOUND 1131 0.0404
256 BUNDLE BRANCH BLOCK RIGHT 185 0.0403
257 SNORING 152 0.0402
258 SELF-INJURIOUS IDEATION 168 0.0400
259 DROOLING 275 0.0398
260 APATHY 578 0.0396
261 DRUG-INDUCED LIVER INJURY 1243 0.0396
262 MYDRIASIS 508 0.0396
263 ELECTROCARDIOGRAM QT PROLONGED 1417 0.0394
264 ILEUS PARALYTIC 175 0.0392
265 AFFECT LABILITY 375 0.0389
266 ANGER 1308 0.0386
267 DISSOCIATION 296 0.0386
268 PRE-EXISTING CONDITION IMPROVED 241 0.0386
269 BALANCE DISORDER 3332 0.0385
270 SOMNOLENCE 7756 0.0385
271 PNEUMONIA ASPIRATION 960 0.0384
272 DYSKINESIA 1546 0.0380
273 IRRITABILITY 2282 0.0379
274 BRADYKINESIA 223 0.0377
275 RESPIRATORY DEPRESSION 463 0.0377
276 EOSINOPHIL COUNT INCREASED 312 0.0374
277 DRUG RESISTANCE 958 0.0373
278 NEUROLOGICAL SYMPTOM 213 0.0372
279 FEELING OF DESPAIR 173 0.0371
280 PAPULE 261 0.0370
281 SOCIAL AVOIDANT BEHAVIOUR 214 0.0369
282 SINUS TACHYCARDIA 525 0.0369
283 INFARCTION 253 0.0369
284 THINKING ABNORMAL 688 0.0369
285 BLISTER 2071 0.0368
286 HYPERPHAGIA 147 0.0368
287 CAESAREAN SECTION 429 0.0368
288 DISTURBANCE IN ATTENTION 1982 0.0367
289 PRESCRIBED OVERDOSE 707 0.0365
290 MYOCARDITIS 414 0.0361
291 DRUG TOLERANCE 182 0.0359
292 SYSTEMIC LUPUS ERYTHEMATOSUS 1260 0.0355
293 SCREAMING 226 0.0354
294 ATTENTION DEFICIT HYPERACTIVITY DISORDER 149 0.0353
295 APHASIA 1067 0.0353
296 DELIRIUM 1223 0.0352
297 PREMATURE LABOUR 199 0.0352
298 BRAIN OEDEMA 444 0.0351
299 MUSCLE TWITCHING 810 0.0351
300 PURPURA 310 0.0350
301 MOTOR DYSFUNCTION 356 0.0349
302 BLOOD CREATINE PHOSPHOKINASE INCREASED 1002 0.0348
303 ADVERSE REACTION 458 0.0345
304 ODYNOPHAGIA 206 0.0345
305 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 305 0.0345
306 PRODUCT SUBSTITUTION ISSUE 1983 0.0344
307 LEUKOCYTOSIS 623 0.0344
308 ATRIOVENTRICULAR BLOCK FIRST DEGREE 149 0.0343
309 MOUTH ULCERATION 724 0.0343
310 DECREASED INTEREST 202 0.0342
311 PHARYNGOLARYNGEAL PAIN 182 0.0342
312 MENTAL IMPAIRMENT 830 0.0342
313 CARDIAC MURMUR 296 0.0342
314 DYSPHEMIA 149 0.0339
315 TRISMUS 174 0.0337
316 ORAL DISORDER 247 0.0337
317 FACIAL PAIN 299 0.0335
318 RHINITIS ALLERGIC 149 0.0334
319 DISORIENTATION 1321 0.0333
320 RESTLESSNESS 1217 0.0332
321 DEPRESSION 7554 0.0332
322 CARDIO-RESPIRATORY ARREST 1386 0.0331
323 MENTAL STATUS CHANGES 920 0.0331
324 PRODUCT ADMINISTRATION INTERRUPTED 259 0.0330
325 HEPATITIS 841 0.0328
326 DYSPHORIA 166 0.0328
327 EXTRAPYRAMIDAL DISORDER 814 0.0327
328 GRANULOCYTOPENIA 186 0.0326
329 BLOOD CHOLESTEROL INCREASED 1502 0.0322
330 PRE-ECLAMPSIA 153 0.0322
331 HAEMODYNAMIC INSTABILITY 245 0.0321
332 SOMNAMBULISM 211 0.0321
333 DRUG SCREEN POSITIVE 254 0.0321
334 PIGMENTATION DISORDER 198 0.0320
335 UNRESPONSIVE TO STIMULI 827 0.0320
336 CONFUSIONAL STATE 5161 0.0319
337 CONCUSSION 247 0.0319
338 PREGNANCY 638 0.0318
339 DYSTONIA 618 0.0318
340 DERMATITIS BULLOUS 230 0.0317
341 LIVER FUNCTION TEST INCREASED 680 0.0316
342 NIGHT SWEATS 1019 0.0316
343 SPEECH DISORDER 1655 0.0316
344 APNOEA 245 0.0314
345 BLOOD LACTATE DEHYDROGENASE INCREASED 497 0.0313
346 CEREBRAL DISORDER 232 0.0313
347 BLOOD LACTIC ACID INCREASED 165 0.0313
348 INCOHERENT 202 0.0312
349 SARCOIDOSIS 148 0.0311
350 CONTRAINDICATED PRODUCT ADMINISTERED 942 0.0311
351 LOW BIRTH WEIGHT BABY 247 0.0311
352 MIOSIS 247 0.0307
353 MOOD ALTERED 839 0.0307
354 BLOOD SODIUM DECREASED 578 0.0306
355 HEPATIC ENZYME INCREASED 2089 0.0306
356 HALLUCINATION, VISUAL 645 0.0305
357 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 237 0.0305
358 EUPHORIC MOOD 312 0.0304
359 ACUTE HEPATIC FAILURE 416 0.0304
360 APLASTIC ANAEMIA 158 0.0302
361 CRYING 1095 0.0301
362 PERSONALITY CHANGE 279 0.0300
363 HEPATOCELLULAR INJURY 425 0.0299
364 ASPIRATION 328 0.0299
365 POST-TRAUMATIC STRESS DISORDER 199 0.0297
366 EXOSTOSIS 269 0.0294
367 METABOLIC DISORDER 171 0.0294
368 INTESTINAL ISCHAEMIA 162 0.0294
369 AMNESIA 1912 0.0294
370 CONJUNCTIVITIS 545 0.0293
371 MOOD SWINGS 935 0.0293
372 RESPIRATORY ARREST 807 0.0292
373 SLEEP DISORDER 2046 0.0290
374 TREMOR 4787 0.0288
375 IMPAIRED HEALING 946 0.0288
376 MEMORY IMPAIRMENT 3954 0.0288
377 NEUTROPHIL COUNT INCREASED 294 0.0287
378 RHABDOMYOLYSIS 1197 0.0287
379 RASH PUSTULAR 207 0.0284
380 DISSEMINATED INTRAVASCULAR COAGULATION 399 0.0283
381 BRAIN INJURY 284 0.0283
382 GAIT INABILITY 942 0.0282
383 URINARY INCONTINENCE 833 0.0281
384 SUDDEN DEATH 297 0.0280
385 HYPERSOMNIA 802 0.0279
386 SLEEP APNOEA SYNDROME 531 0.0278
387 PHOTOPHOBIA 523 0.0278
388 HYPERPROLACTINAEMIA 180 0.0277
389 VISUAL DISTURBANCE 159 0.0277
390 DYSGRAPHIA 181 0.0274
391 FOETAL GROWTH RESTRICTION 167 0.0274
392 AGRANULOCYTOSIS 509 0.0274
393 OSTEOARTHRITIS 1157 0.0273
394 BLOOD ALKALINE PHOSPHATASE INCREASED 675 0.0272
395 OVERWEIGHT 146 0.0272
396 PREMATURE BABY 817 0.0271
397 VERTIGO 1648 0.0270
398 MENTAL DISORDER 1161 0.0267
399 ACIDOSIS 203 0.0265
400 HEPATIC FUNCTION ABNORMAL 989 0.0265
401 FAECALOMA 145 0.0264
402 HEAD INJURY 837 0.0264
403 HEPATOMEGALY 258 0.0262
404 LETHARGY 1506 0.0262
405 RED BLOOD CELL SEDIMENTATION RATE INCREASED 289 0.0261
406 HYPERVENTILATION 151 0.0260
407 PSORIATIC ARTHROPATHY 1057 0.0260
408 LUPUS-LIKE SYNDROME 236 0.0260
409 INFLAMMATION 1338 0.0259
410 METABOLIC ACIDOSIS 829 0.0259
411 DEPRESSED MOOD 1369 0.0259
412 ERYTHEMA OF EYELID 140 0.0258
413 MOBILITY DECREASED 1851 0.0257
414 TRANSAMINASES INCREASED 572 0.0257
415 ALANINE AMINOTRANSFERASE INCREASED 1573 0.0256
416 SHOCK 586 0.0255
417 RASH 11101 0.0254
418 ASPARTATE AMINOTRANSFERASE INCREASED 1348 0.0254
419 LOSS OF CONSCIOUSNESS 3241 0.0253
420 RHEUMATOID FACTOR POSITIVE 146 0.0253
421 TREATMENT NONCOMPLIANCE 1382 0.0252
422 PANIC ATTACK 914 0.0251
423 INCONTINENCE 265 0.0250
424 TARDIVE DYSKINESIA 706 0.0250
425 WITHDRAWAL SYNDROME 1045 0.0249
426 MIGRAINE 2375 0.0249
427 ARTERIOSCLEROSIS CORONARY ARTERY 164 0.0247
428 TONGUE DISORDER 179 0.0247
429 LOWER RESPIRATORY TRACT INFECTION 1125 0.0247
430 PETECHIAE 257 0.0246
431 TYPE 1 DIABETES MELLITUS 148 0.0245
432 SINUS BRADYCARDIA 235 0.0243
433 GASTROOESOPHAGEAL REFLUX DISEASE 1956 0.0243
434 VITAMIN D DEFICIENCY 236 0.0242
435 DRUG ABUSE 2002 0.0240
436 RASH ERYTHEMATOUS 1149 0.0240
437 VISUAL FIELD DEFECT 173 0.0239
438 IMPAIRED DRIVING ABILITY 272 0.0239
439 HYPOKINESIA 347 0.0239
440 WHITE BLOOD CELL COUNT INCREASED 917 0.0239
441 PRESCRIBED UNDERDOSE 474 0.0237
442 HEPATOTOXICITY 529 0.0237
443 DRUG DISPENSING ERROR 363 0.0237
444 RESTLESS LEGS SYNDROME 431 0.0237
445 OVERDOSE 5089 0.0236
446 NIGHTMARE 811 0.0234
447 WHEEZING 1389 0.0234
448 ATRIOVENTRICULAR BLOCK 181 0.0234
449 DERMATITIS ALLERGIC 293 0.0233
450 MATERNAL EXPOSURE BEFORE PREGNANCY 159 0.0233
451 ENCEPHALITIS 161 0.0232
452 CARDIAC ARREST 1917 0.0232
453 BODY TEMPERATURE INCREASED 473 0.0232
454 LEUKOPENIA 1158 0.0231
455 PRODUCT SUPPLY ISSUE 165 0.0231
456 STOMATITIS 1396 0.0230
457 MIDDLE INSOMNIA 428 0.0229
458 INITIAL INSOMNIA 235 0.0229
459 RASH PAPULAR 513 0.0229
460 ATRIOVENTRICULAR BLOCK COMPLETE 153 0.0228
461 NECK PAIN 1273 0.0228
462 HYPOALBUMINAEMIA 177 0.0227
463 HYPERTRANSAMINASAEMIA 158 0.0227
464 SCAB 259 0.0227
465 SKIN LESION 622 0.0227
466 EATING DISORDER 480 0.0225
467 EAR PAIN 438 0.0225
468 INCREASED APPETITE 430 0.0225
469 HEPATITIS ACUTE 146 0.0224
470 TORSADE DE POINTES 176 0.0224
471 TACHYCARDIA 1992 0.0224
472 LUNG DISORDER 1094 0.0223
473 PYREXIA 7715 0.0223
474 DRY MOUTH 1807 0.0222
475 TACHYPNOEA 301 0.0221
476 WRONG PRODUCT ADMINISTERED 149 0.0220
477 CHOLESTASIS 423 0.0220
478 ULCER HAEMORRHAGE 148 0.0218
479 CIRCULATORY COLLAPSE 372 0.0218
480 URINARY RETENTION 727 0.0218
481 SLUGGISHNESS 222 0.0217
482 PHARYNGITIS 269 0.0217
483 SUBSTANCE ABUSE 176 0.0216
484 CENTRAL NERVOUS SYSTEM LESION 297 0.0216
485 FEAR 580 0.0215
486 ANXIETY 6135 0.0215
487 FALL 7154 0.0215
488 BRADYCARDIA 1138 0.0214
489 ACUTE RESPIRATORY DISTRESS SYNDROME 378 0.0214
490 HALLUCINATION 1610 0.0213
491 ARTHROPATHY 1185 0.0213
492 CONDITION AGGRAVATED 6474 0.0213
493 RESPIRATORY RATE INCREASED 189 0.0213
494 APPETITE DISORDER 141 0.0212
495 ANOREXIA 274 0.0212
496 DRUG INTOLERANCE 2047 0.0212
497 ELECTROCARDIOGRAM ABNORMAL 166 0.0211
498 MULTI-ORGAN FAILURE 365 0.0211
499 HEPATIC STEATOSIS 393 0.0211
500 BRONCHIECTASIS 141 0.0209
501 BLOOD ALBUMIN DECREASED 166 0.0209
502 TREATMENT FAILURE 1730 0.0209
503 UNINTENDED PREGNANCY 218 0.0208
504 THERMAL BURN 148 0.0208
505 HYPOTHYROIDISM 666 0.0208
506 WEIGHT INCREASED 4665 0.0208
507 VENTRICULAR FIBRILLATION 230 0.0207
508 SENSORY DISTURBANCE 330 0.0205
509 CYANOSIS 322 0.0205
510 HEMIPARESIS 346 0.0204
511 MEDICATION ERROR 1135 0.0204
512 GAIT DISTURBANCE 3862 0.0202
513 EMOTIONAL DISORDER 622 0.0202
514 PANCREATITIS ACUTE 453 0.0201
515 INSOMNIA 5364 0.0201
516 FOOT DEFORMITY 223 0.0201
517 AUTOIMMUNE DISORDER 196 0.0201
518 HEPATIC FAILURE 605 0.0200
519 PHOTOSENSITIVITY REACTION 331 0.0200
520 LIVER FUNCTION TEST ABNORMAL 582 0.0200
521 ACCIDENTAL OVERDOSE 732 0.0200
522 POOR QUALITY SLEEP 430 0.0200
523 OBSTRUCTIVE AIRWAYS DISORDER 222 0.0199
524 ILEUS 248 0.0199
525 MUSCULOSKELETAL PAIN 1044 0.0199
526 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 955 0.0199
527 EYELID OEDEMA 231 0.0199
528 THERAPEUTIC PRODUCT EFFECT DECREASED 890 0.0199
529 ANURIA 171 0.0198
530 JOINT DISLOCATION 210 0.0198
531 MUSCLE SPASTICITY 244 0.0198
532 DYSPHAGIA 1880 0.0198
533 LYMPHOPENIA 279 0.0197
534 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1077 0.0196
535 PREMATURE DELIVERY 309 0.0194
536 HEMIPLEGIA 161 0.0193
537 SEXUAL DYSFUNCTION 226 0.0193
538 BLOOD TRIGLYCERIDES INCREASED 340 0.0192
539 GENERAL PHYSICAL HEALTH DETERIORATION 2222 0.0192
540 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1355 0.0190
541 ILL-DEFINED DISORDER 1153 0.0190
542 THERAPY PARTIAL RESPONDER 296 0.0190
543 RASH MACULAR 662 0.0189
544 BLADDER DISORDER 188 0.0189
545 HYPERLIPIDAEMIA 226 0.0189
546 PARALYSIS 270 0.0188
547 CARDIOMEGALY 232 0.0188
548 PRODUCT AVAILABILITY ISSUE 429 0.0188
549 HYPOAESTHESIA 2811 0.0188
550 EYE DISCHARGE 194 0.0187
551 MOVEMENT DISORDER 598 0.0186
552 SCAR 318 0.0186
553 ORAL PAIN 413 0.0184
554 DIZZINESS 9167 0.0184
555 TUBULOINTERSTITIAL NEPHRITIS 344 0.0183
556 IMPAIRED WORK ABILITY 392 0.0183
557 LYMPHOCYTE COUNT DECREASED 324 0.0183
558 LIVER DISORDER 810 0.0182
559 SENSORY LOSS 147 0.0182
560 HYPOTENSION 3658 0.0182
561 NEURALGIA 443 0.0182
562 BRAIN NEOPLASM 167 0.0182
563 BLOOD BILIRUBIN INCREASED 491 0.0182
564 CHOLELITHIASIS 595 0.0181
565 MUSCULAR WEAKNESS 2062 0.0181
566 ROAD TRAFFIC ACCIDENT 759 0.0181
567 ELECTROLYTE IMBALANCE 210 0.0181
568 POLYURIA 148 0.0181
569 SWELLING 1675 0.0179
570 MENSTRUAL DISORDER 148 0.0179
571 NEUROTOXICITY 313 0.0178
572 SPLENOMEGALY 209 0.0178
573 RESPIRATORY DISTRESS 492 0.0178
574 THERAPY NON-RESPONDER 793 0.0176
575 HAEMODIALYSIS 148 0.0176
576 INFUSION RELATED REACTION 1161 0.0175
577 LIP SWELLING 583 0.0175
578 ATELECTASIS 169 0.0175
579 INTENTIONAL PRODUCT USE ISSUE 1530 0.0174
580 DECREASED ACTIVITY 188 0.0174
581 HAEMATOCRIT DECREASED 345 0.0174
582 DEMENTIA 486 0.0174
583 OSTEOPENIA 263 0.0173
584 MULTIPLE ORGAN DYSFUNCTION SYNDROME 490 0.0173
585 VISION BLURRED 2372 0.0173
586 HEPATIC CYTOLYSIS 220 0.0172
587 DISABILITY 340 0.0172
588 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 294 0.0171
589 INJURY 1202 0.0171
590 NERVOUSNESS 893 0.0171
591 PARAESTHESIA 2672 0.0170
592 HYPOKALAEMIA 780 0.0169
593 CHOKING 329 0.0168
594 PERIPHERAL COLDNESS 231 0.0168
595 PANCREATITIS 884 0.0167
596 ACTIVITIES OF DAILY LIVING IMPAIRED 331 0.0167
597 VOMITING 7838 0.0167
598 NERVOUS SYSTEM DISORDER 519 0.0166
599 COAGULOPATHY 277 0.0166
600 THROMBOCYTOPENIA 1855 0.0166
601 ABNORMAL DREAMS 457 0.0165
602 DYSSTASIA 483 0.0165
603 FOOT FRACTURE 313 0.0165
604 MUSCULOSKELETAL STIFFNESS 1445 0.0165
605 PRODUCT USE IN UNAPPROVED INDICATION 4087 0.0165
606 RASH PRURITIC 893 0.0165
607 HYPOCALCAEMIA 310 0.0164
608 IMPAIRED GASTRIC EMPTYING 223 0.0163
609 TENDERNESS 170 0.0163
610 BEDRIDDEN 214 0.0163
611 PALLOR 438 0.0161
612 LOWER LIMB FRACTURE 308 0.0160
613 DENTAL CARIES 177 0.0160
614 THIRST 285 0.0159
615 PHARMACEUTICAL PRODUCT COMPLAINT 413 0.0159
616 NO THERAPEUTIC RESPONSE 193 0.0158
617 ECONOMIC PROBLEM 239 0.0158
618 RESPIRATORY FAILURE 1147 0.0157
619 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 150 0.0157
620 SCIATICA 249 0.0156
621 SWOLLEN TONGUE 486 0.0155
622 DIABETES MELLITUS 1183 0.0155
623 VENTRICULAR TACHYCARDIA 256 0.0155
624 LIGAMENT SPRAIN 152 0.0154
625 ABASIA 379 0.0153
626 HYPOXIA 540 0.0153
627 DRUG ADMINISTRATION ERROR 470 0.0153
628 URTICARIA 2560 0.0153
629 FULL BLOOD COUNT ABNORMAL 161 0.0152
630 PANCYTOPENIA 846 0.0151
631 PRODUCT ADMINISTRATION ERROR 305 0.0151
632 REBOUND EFFECT 170 0.0150
633 HYPERTENSION 3179 0.0150
634 BLOOD UREA INCREASED 251 0.0150
635 CONTUSION 1441 0.0150
636 FEELING ABNORMAL 3580 0.0149
637 TEMPERATURE INTOLERANCE 154 0.0149
638 RETCHING 316 0.0148
639 MICTURITION URGENCY 169 0.0148
640 FEEDING DISORDER 300 0.0148
641 MALNUTRITION 165 0.0147
642 BODY TEMPERATURE DECREASED 145 0.0147
643 PULMONARY FIBROSIS 282 0.0147
644 OEDEMA 797 0.0147
645 SKIN DISORDER 489 0.0146
646 TINNITUS 673 0.0146
647 MUSCLE TIGHTNESS 236 0.0146
648 SKIN EXFOLIATION 1228 0.0145
649 SKIN REACTION 205 0.0145
650 ANKLE FRACTURE 224 0.0145
651 RESPIRATORY DISORDER 432 0.0144
652 HYPOPHAGIA 369 0.0144
653 DYSURIA 530 0.0144
654 RED BLOOD CELL COUNT DECREASED 411 0.0144
655 SYNCOPE 1438 0.0144
656 EAR INFECTION 382 0.0143
657 PLATELET COUNT INCREASED 187 0.0143
658 VASCULITIS 166 0.0142
659 INABILITY TO AFFORD MEDICATION 141 0.0142
660 VENTRICULAR EXTRASYSTOLES 147 0.0141
661 PHARYNGEAL OEDEMA 217 0.0141
662 OSTEOPOROSIS 577 0.0140
663 DYSPEPSIA 1377 0.0140
664 SWELLING FACE 911 0.0140
665 ACUTE RESPIRATORY FAILURE 269 0.0140
666 BRAIN FOG 219 0.0140
667 INTENTIONAL DRUG MISUSE 292 0.0140
668 HYPERGLYCAEMIA 506 0.0139
669 DISEASE RECURRENCE 660 0.0139
670 THERAPEUTIC RESPONSE UNEXPECTED 620 0.0138
671 PRODUCT PRESCRIBING ERROR 329 0.0138
672 HUNGER 192 0.0138
673 RIB FRACTURE 283 0.0137
674 JAUNDICE 369 0.0137
675 CARDIOGENIC SHOCK 196 0.0136
676 QUALITY OF LIFE DECREASED 183 0.0136
677 ALOPECIA 2678 0.0136
678 HYPERHIDROSIS 1751 0.0136
679 CONSTIPATION 2946 0.0135
680 DIABETES MELLITUS INADEQUATE CONTROL 239 0.0135
681 GENERALISED OEDEMA 167 0.0135
682 ORAL CANDIDIASIS 177 0.0134
683 ERECTILE DYSFUNCTION 345 0.0134
684 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 228 0.0134
685 HYPOAESTHESIA ORAL 202 0.0134
686 MUSCLE SPASMS 2457 0.0134
687 MULTIPLE SCLEROSIS 640 0.0134
688 FEELING JITTERY 255 0.0134
689 INTENTIONAL PRODUCT MISUSE 1169 0.0133
690 SUBDURAL HAEMATOMA 191 0.0133
691 HEADACHE 8311 0.0132
692 INTERVERTEBRAL DISC PROTRUSION 289 0.0132
693 ARRHYTHMIA 626 0.0132
694 HEAD DISCOMFORT 234 0.0132
695 ASTHENIA 4967 0.0132
696 PRURITUS GENERALISED 285 0.0132
697 VISUAL ACUITY REDUCED 437 0.0131
698 HYPERSENSITIVITY 2426 0.0131
699 ANHEDONIA 343 0.0130
700 INTERNATIONAL NORMALISED RATIO INCREASED 372 0.0130
701 GASTROINTESTINAL DISORDER 1168 0.0130
702 OXYGEN SATURATION DECREASED 731 0.0130
703 MITRAL VALVE INCOMPETENCE 147 0.0130
704 DRUG INEFFECTIVE 17083 0.0129
705 DECREASED APPETITE 3002 0.0129
706 WHITE BLOOD CELL COUNT DECREASED 1401 0.0129
707 ABDOMINAL DISCOMFORT 2153 0.0128
708 OROPHARYNGEAL PAIN 1185 0.0128
709 ERYTHEMA 2629 0.0128
710 ADVERSE DRUG REACTION 1148 0.0128
711 EYE DISORDER 419 0.0127
712 DISCOMFORT 775 0.0127
713 HYPOGLYCAEMIA 614 0.0126
714 MULTIPLE SCLEROSIS RELAPSE 865 0.0126
715 ABDOMINAL DISTENSION 1316 0.0126
716 AMENORRHOEA 220 0.0125
717 BLOOD POTASSIUM DECREASED 377 0.0125
718 ABDOMINAL PAIN UPPER 2562 0.0124
719 MUSCLE ATROPHY 157 0.0124
720 VISUAL IMPAIRMENT 1531 0.0123
721 METRORRHAGIA 210 0.0123
722 JOINT INJURY 263 0.0123
723 ACCIDENT 147 0.0123
724 UPPER LIMB FRACTURE 245 0.0123
725 SKIN DISCOLOURATION 565 0.0123
726 PNEUMONIA 3968 0.0122
727 DRUG PRESCRIBING ERROR 235 0.0122
728 OEDEMA PERIPHERAL 1487 0.0122
729 URINARY TRACT INFECTION 2076 0.0122
730 DERMATITIS 255 0.0122
731 PRODUCT USE ISSUE 2283 0.0121
732 COLD SWEAT 213 0.0121
733 KNEE ARTHROPLASTY 254 0.0121
734 NEUTROPHIL COUNT DECREASED 491 0.0120
735 POLYNEUROPATHY 144 0.0120
736 UNDERDOSE 876 0.0120
737 DIABETIC KETOACIDOSIS 288 0.0120
738 MALAISE 5250 0.0120
739 PRODUCT QUALITY ISSUE 1624 0.0119
740 OFF LABEL USE 10461 0.0119
741 NAUSEA 9453 0.0119
742 PERICARDIAL EFFUSION 276 0.0119
743 THERAPEUTIC RESPONSE DECREASED 720 0.0119
744 PARAESTHESIA ORAL 171 0.0118
745 RENAL FAILURE ACUTE 503 0.0118
746 WEIGHT DECREASED 3295 0.0118
747 UPPER RESPIRATORY TRACT INFECTION 544 0.0118
748 HAEMATOMA 305 0.0118
749 INSURANCE ISSUE 180 0.0118
750 FATIGUE 9146 0.0117
751 CHROMATURIA 265 0.0117
752 PRURITUS 4511 0.0117
753 DRUG WITHDRAWAL SYNDROME NEONATAL 173 0.0117
754 THROAT TIGHTNESS 314 0.0116
755 VIRAL INFECTION 386 0.0116
756 GASTROENTERITIS VIRAL 209 0.0116
757 STAPHYLOCOCCAL INFECTION 380 0.0115
758 BURNING SENSATION 807 0.0115
759 NEPHROLITHIASIS 527 0.0115
760 PULMONARY CONGESTION 151 0.0114
761 HEART RATE INCREASED 1131 0.0114
762 BLOOD PRESSURE DECREASED 756 0.0114
763 ORAL DISCOMFORT 158 0.0114
764 LOCAL SWELLING 198 0.0113
765 GASTRITIS 298 0.0113
766 INFLUENZA LIKE ILLNESS 929 0.0113
767 GINGIVAL BLEEDING 154 0.0113
768 GASTROENTERITIS 164 0.0112
769 POLLAKIURIA 467 0.0112
770 NEUTROPENIA 1517 0.0111
771 BLINDNESS 453 0.0111
772 OCULAR HYPERAEMIA 527 0.0111
773 TOOTH DISORDER 246 0.0111
774 HEPATIC CIRRHOSIS 207 0.0110
775 PERIPHERAL SWELLING 1690 0.0110
776 CARPAL TUNNEL SYNDROME 153 0.0109
777 JOINT SWELLING 1317 0.0109
778 TOOTHACHE 196 0.0108
779 FEELING HOT 661 0.0108
780 NASOPHARYNGITIS 1985 0.0108
781 ABDOMINAL PAIN 2501 0.0107
782 DEHYDRATION 1429 0.0107
783 LIMB DISCOMFORT 329 0.0106
784 ULCER 168 0.0105
785 BLOOD CREATININE INCREASED 689 0.0105
786 DRUG WITHDRAWAL SYNDROME 925 0.0105
787 ACUTE KIDNEY INJURY 1612 0.0105
788 RHEUMATOID ARTHRITIS 1190 0.0105
789 EYE PAIN 589 0.0104
790 SEPTIC SHOCK 454 0.0104
791 LIMB INJURY 283 0.0104
792 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 543 0.0104
793 PRODUCT DISPENSING ERROR 226 0.0104
794 RESPIRATORY TRACT INFECTION 270 0.0104
795 PAIN 6366 0.0104
796 KIDNEY INFECTION 203 0.0103
797 MUSCULOSKELETAL CHEST PAIN 160 0.0103
798 WRONG TECHNIQUE IN DRUG USAGE PROCESS 375 0.0103
799 ADVERSE EVENT 942 0.0102
800 DEAFNESS 267 0.0102
801 BRONCHITIS 753 0.0102
802 CYSTITIS 323 0.0101
803 PLATELET COUNT DECREASED 1080 0.0101
804 FEELING COLD 280 0.0100
805 MENORRHAGIA 197 0.0100
806 CHEST PAIN 1857 0.0100
807 PRESYNCOPE 243 0.0100
808 CHILLS 1171 0.0100
809 CARDIOMYOPATHY 147 0.0099
810 HAEMATEMESIS 252 0.0099
811 FRACTURE 188 0.0099
812 JOINT STIFFNESS 260 0.0099
813 BACTERIAL INFECTION 184 0.0099
814 THYROID DISORDER 151 0.0098
815 IMMUNODEFICIENCY 146 0.0098
816 SEPSIS 1088 0.0097
817 PLEURAL EFFUSION 587 0.0096
818 CANDIDA INFECTION 162 0.0096
819 PALPITATIONS 1122 0.0096
820 PROTEINURIA 181 0.0095
821 HEART RATE DECREASED 334 0.0095
822 BACK DISORDER 154 0.0095
823 TRANSIENT ISCHAEMIC ATTACK 319 0.0094
824 ECZEMA 492 0.0094
825 BLOOD POTASSIUM INCREASED 152 0.0094
826 PULMONARY OEDEMA 419 0.0093
827 BLOOD PRESSURE SYSTOLIC INCREASED 182 0.0093
828 LACTIC ACIDOSIS 302 0.0093
829 PAIN IN EXTREMITY 2739 0.0093
830 ASTHMA 1046 0.0092
831 PRODUCTIVE COUGH 441 0.0092
832 EYE SWELLING 342 0.0092
833 DRUG EFFECT DECREASED 493 0.0091
834 ABSCESS 146 0.0091
835 CELLULITIS 461 0.0091
836 RENAL FAILURE 1211 0.0091
837 DRY EYE 452 0.0090
838 BONE DISORDER 165 0.0090
839 BLOOD PRESSURE FLUCTUATION 216 0.0090
840 HAEMOGLOBIN DECREASED 924 0.0090
841 MYALGIA 1528 0.0090
842 PULMONARY EMBOLISM 852 0.0090
843 POST PROCEDURAL COMPLICATION 172 0.0089
844 CHRONIC KIDNEY DISEASE 676 0.0089
845 CEREBRAL HAEMORRHAGE 318 0.0089
846 SURGERY 520 0.0089
847 BLOOD PRESSURE INCREASED 1355 0.0089
848 PRODUCT PRESCRIBING ISSUE 193 0.0089
849 THERAPY CESSATION 454 0.0088
850 INJECTION SITE REACTION 605 0.0088
851 SINUSITIS 899 0.0088
852 BONE MARROW FAILURE 177 0.0087
853 RENAL IMPAIRMENT 727 0.0086
854 ANGIOEDEMA 382 0.0086
855 HEART RATE IRREGULAR 195 0.0086
856 GALLBLADDER DISORDER 154 0.0086
857 GLAUCOMA 166 0.0086
858 BLOOD PRESSURE ABNORMAL 171 0.0086
859 DYSPNOEA 4851 0.0086
860 CEREBRAL INFARCTION 208 0.0085
861 DEEP VEIN THROMBOSIS 552 0.0085
862 FREQUENT BOWEL MOVEMENTS 228 0.0084
863 BACK PAIN 1960 0.0084
864 INTENTIONAL DOSE OMISSION 240 0.0084
865 RENAL DISORDER 391 0.0084
866 INFECTION 1210 0.0084
867 ORAL HERPES 163 0.0083
868 DRUG EFFECT INCOMPLETE 303 0.0083
869 INFLUENZA 930 0.0083
870 DRUG DOSE OMISSION 1378 0.0083
871 HAEMATURIA 285 0.0083
872 ARTHRALGIA 3453 0.0083
873 ANAEMIA 1583 0.0083
874 HAEMOPTYSIS 231 0.0083
875 DIARRHOEA 5343 0.0083
876 HYPERKALAEMIA 289 0.0082
877 DYSGEUSIA 611 0.0082
878 SKIN ULCER 212 0.0082
879 INTESTINAL OBSTRUCTION 307 0.0081
880 DYSPHONIA 473 0.0081
881 HERNIA 156 0.0081
882 UNEVALUABLE EVENT 609 0.0080
883 HOSPITALISATION 1236 0.0080
884 SPINAL FRACTURE 160 0.0080
885 RHINORRHOEA 516 0.0080
886 COUGH 2231 0.0079
887 FLUSHING 808 0.0079
888 ANGINA PECTORIS 226 0.0079
889 MUCOSAL INFLAMMATION 206 0.0079
890 PAIN IN JAW 221 0.0078
891 RECTAL HAEMORRHAGE 334 0.0078
892 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 551 0.0077
893 HIP FRACTURE 249 0.0077
894 PRODUCT DOSE OMISSION ISSUE 2272 0.0077
895 GASTRIC ULCER 145 0.0076
896 SNEEZING 171 0.0076
897 PRODUCT PHYSICAL ISSUE 152 0.0075
898 CHEST DISCOMFORT 767 0.0075
899 ILLNESS 769 0.0075
900 NASAL CONGESTION 438 0.0074
901 FAECES DISCOLOURED 161 0.0074
902 SINUS DISORDER 147 0.0074
903 VAGINAL HAEMORRHAGE 321 0.0074
904 MENSTRUATION IRREGULAR 198 0.0074
905 ANAPHYLACTIC REACTION 408 0.0074
906 INCORRECT PRODUCT ADMINISTRATION DURATION 159 0.0073
907 ABDOMINAL PAIN LOWER 185 0.0073
908 HYPOACUSIS 313 0.0073
909 NEUROPATHY PERIPHERAL 689 0.0072
910 EPISTAXIS 540 0.0072
911 CLOSTRIDIUM DIFFICILE INFECTION 157 0.0072
912 CEREBROVASCULAR ACCIDENT 1218 0.0072
913 HAEMORRHOIDS 140 0.0072
914 INTERSTITIAL LUNG DISEASE 347 0.0072
915 PULMONARY HYPERTENSION 148 0.0071
916 CATARACT 421 0.0071
917 TOOTH LOSS 144 0.0069
918 PRODUCT DOSE OMISSION 453 0.0069
919 FUNGAL INFECTION 230 0.0069
920 LACRIMATION INCREASED 205 0.0068
921 HERPES ZOSTER 389 0.0068
922 ARTHRITIS 531 0.0067
923 FEMUR FRACTURE 207 0.0067
924 GASTRIC DISORDER 229 0.0067
925 BONE PAIN 390 0.0067
926 DYSPNOEA EXERTIONAL 248 0.0066
927 LABORATORY TEST ABNORMAL 193 0.0065
928 THROMBOSIS 518 0.0064
929 EMOTIONAL DISTRESS 772 0.0064
930 FLATULENCE 361 0.0064
931 ACNE 480 0.0063
932 HOT FLUSH 477 0.0063
933 COVID-19 1110 0.0063
934 AGEUSIA 153 0.0061
935 COLITIS 232 0.0061
936 INCORRECT DOSE ADMINISTERED 1383 0.0061
937 ASCITES 178 0.0060
938 HAEMATOCHEZIA 334 0.0060
939 LUNG NEOPLASM MALIGNANT 246 0.0060
940 PAIN OF SKIN 161 0.0060
941 CARDIAC FAILURE 480 0.0060
942 FLUID RETENTION 301 0.0059
943 EYE PRURITUS 196 0.0058
944 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1179 0.0058
945 CARDIAC DISORDER 527 0.0056
946 ACUTE MYOCARDIAL INFARCTION 165 0.0056
947 EYE IRRITATION 322 0.0056
948 ATRIAL FIBRILLATION 540 0.0055
949 HAEMORRHAGE 575 0.0055
950 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 989 0.0055
951 PNEUMONITIS 149 0.0055
952 PROCEDURAL PAIN 151 0.0054
953 THROAT IRRITATION 242 0.0054
954 RENAL INJURY 160 0.0054
955 THERAPY INTERRUPTED 378 0.0053
956 GYNAECOMASTIA 160 0.0052
957 BLOOD GLUCOSE DECREASED 242 0.0050
958 OSTEONECROSIS 163 0.0050
959 DRUG DEPENDENCE 796 0.0049
960 BLOOD GLUCOSE INCREASED 922 0.0049
961 DISEASE PROGRESSION 564 0.0048
962 PSORIASIS 622 0.0048
963 THERAPEUTIC RESPONSE SHORTENED 156 0.0047
964 CORONARY ARTERY DISEASE 142 0.0047
965 SKIN BURNING SENSATION 325 0.0045
966 EXTRA DOSE ADMINISTERED 183 0.0045
967 BONE DENSITY DECREASED 141 0.0045
968 EXPIRED PRODUCT ADMINISTERED 149 0.0045
969 INJECTION SITE MASS 163 0.0044
970 DRY SKIN 581 0.0043
971 GASTROINTESTINAL HAEMORRHAGE 359 0.0043
972 MYOCARDIAL INFARCTION 747 0.0043
973 DEVICE DISLOCATION 171 0.0039
974 DERMATITIS ATOPIC 206 0.0039
975 NO ADVERSE EVENT 683 0.0038
976 FEBRILE NEUTROPENIA 248 0.0037
977 DEATH 3070 0.0036
978 CARDIAC FAILURE CONGESTIVE 280 0.0035
979 NEOPLASM MALIGNANT 231 0.0035
980 COLITIS ULCERATIVE 154 0.0034
981 INJECTION SITE BRUISING 257 0.0032
982 INJECTION SITE ERYTHEMA 390 0.0031
983 INJECTION SITE PAIN 919 0.0030
984 INJECTION SITE SWELLING 224 0.0029
985 INJECTION SITE PRURITUS 189 0.0028
986 MALIGNANT NEOPLASM PROGRESSION 278 0.0027
987 INJECTION SITE HAEMORRHAGE 216 0.0027
988 ACCIDENTAL EXPOSURE TO PRODUCT 272 0.0026
989 BREAST CANCER 236 0.0025
990 DEVICE ISSUE 216 0.0024
991 DEVICE MALFUNCTION 166 0.0024